Inhibition of unnecessary RV pacing with AV search hysteresis in ICDs (INTRINSIC RV): Design and clinical protocol

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 1, 2005, Pages 62-66

  Olshansky, Brian ^a   Day, John ^b   McGuire, Maureen ^c   Pratt, Tim ^c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Latter Day Saints Hospital   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Heart failure; Implantable defibrillators; Total mortality; Ventricular pacing

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PACING; HOSPITALIZATION; HUMAN; HYSTERESIS; LIFE EVENT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

CLINICAL PROTOCOLS; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; MULTICENTER STUDIES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 12844258213     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.09456.x     Document Type: Article

References (27)

1. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med 2003; 138:445-452.
2. Buxton AE. The clinical use of implantable cardioverter defibrillators: Where are we now? Where should we go? Ann Intern Med 2003; 138:512-514.
3. Wu LA, Kottke TE, Friedman PA, Luria DM, et al. Implantable cardioverter defibrillator implantation rates in the Olmsted County, Minnesota, population: 1989-1999. J Clin Epidemiol 2002; 55:458-461.
4. Hlatky MA, Saynina O, McDonald KM, et al. Utilization and outcomes of the implantable cardioverter defibrillator, 1987-1995. Am Heart J 2002; 144:397-403.
5. Boehmer JP. Device therapy for heart failure. Am J Cardiol 2003; 91:53-59.
6. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The dual chamber and VVI implantable defibrillator (DAVID) Trial. JAMA 2002; 288:3115-3123.
7. Lamas GA, Lee K, Sweeney M, et al. The mode selection trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J 2000; 140:541-551.
8. Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 1998; 338:1097-1104.
9. Saxon LA, Stevenson WG, Middlekauff HR, et al. Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. Am Heart J 1993; 125:1306-1310.
10. Steinberg JS, Maniar P, Zareba W, et al. For the MADIT-II Investigators. The relationship between right ventricular pacing and outcomes in MADIT-II patients. Program and abstracts from the North American Society of Pacing and Electrophysiology Annual Scientific Sessions; May 14-17, 2003; Washington, DC.
11. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000; 342:1385-1391.
12. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107:2932-2937.
13. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210-1216.
14. Nielson JC, Kristensen L, Andersen HR, et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcome. J Am Coll Cardiol 2003; 42:614-623.
15. Connolly SJ, Kerr C, Gent M, et al. Dual-chamber versus ventricular pacing. Critical appraisal of current data. Circulation 1996; 94:578-583.
16. Gold MR, Brockman R, Peters RW, et al. Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 85:1106-1109.
17. Alpert MA, Curtis JJ, Sanfelippo JF, et al. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. J Am Coll Cardiol 1986; 7:925-932.
18. Marquis DR 7274 Dual Chamber Implantable Cardioverter Defibrillator Reference Manual, © Medtronic, Inc. 2002.
19. Marquis VR 7230 Single Chamber Implantable Cardioverter Defibrillator Reference Manual, © Medtronic, Inc. 2002.
20. Epic+ Model V-236/Model V-196 Implantable Cardioverter Defibrillator User's Manual, © 2003 St. Jude Medical, Cardiac Rhythm Management Division.
21. Silverman R, Casavant D, Loucks S, et al. Atrioventricular interval search: A dual-chamber pacemaker feature to promote intrinsic A-V conduction. (abstract) PACE 1998; 22:873.
22. Deering TF, Wilensky M, Tondato F, et al. Auto intrinsic conduction search algorithm: A prospective analysis. (abstract) PACE 2003; 26:1080.
23. Sweeney MO, Shea JB, Fox V, et al. Randomized trial of a new minimal ventricular pacing mode in dual chamber ICDs. (abstract) PACE 2003; 26:973.
24. Hunt SA, Baker DW, Chin MH, et al. ACG/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2001 American College of Cardiology Web site. Available at: http://www.acc.org/clinical/guidelines/failure/hf_index.htm.
25. Ware JE, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30:473-483.
26. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70:659-663.
27. Chan I. Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies. Statistics in Medicine 1998; 17:1403-1413.